Clinical trials show progress in migraine frequency, skin cancer prevention
-
4:56
What to expect on I-41 and I-94 amid construction
-
1:30
Milwaukee airport prepares for a busy holiday travel week
-
2:02
Staying mild through Christmas with a few sprinkles possible...
-
3:17
Natalie’s Everyday Heroes: A holiday tradition carries on after...
-
3:22
Prescription drugs expected to become less affordable in 2026...
-
2:49
Family mourns father of 3 killed in alleged drunk driving hit-and-run...
-
1:24
Baird Center prepares for 38th annual Christmas Feast
-
0:47
Milwaukee’s Walnut Way Conservation Corp offering free bag...
-
2:23
’Porch pirate’ caught on camera stealing holiday gifts from...
-
1:56
’Just a freak accident’: Multiple horses killed in Kenosha...
-
2:54
Give the gift of creativity this holiday with Grey House Studio
-
5:33
Best Buddies State Showdown: Support people of all abilities
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.